Nemaura Medical Inc
F:N18A

Watchlist Manager
Nemaura Medical Inc Logo
Nemaura Medical Inc
F:N18A
Watchlist
Price: 0.115 EUR
Market Cap: 3.3m EUR

Nemaura Medical Inc
Depreciation & Amortization

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Nemaura Medical Inc
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Nemaura Medical Inc
F:N18A
Depreciation & Amortization
$479.7k
CAGR 3-Years
90%
CAGR 5-Years
74%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Depreciation & Amortization
$2.5B
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
11%
Boston Scientific Corp
NYSE:BSX
Depreciation & Amortization
$1.4B
CAGR 3-Years
6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Depreciation & Amortization
$1.1B
CAGR 3-Years
5%
CAGR 5-Years
8%
CAGR 10-Years
11%
Abbott Laboratories
NYSE:ABT
Depreciation & Amortization
$3.1B
CAGR 3-Years
-2%
CAGR 5-Years
-1%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Depreciation & Amortization
$619m
CAGR 3-Years
19%
CAGR 5-Years
17%
CAGR 10-Years
22%
No Stocks Found

Nemaura Medical Inc
Glance View

Market Cap
3.3m EUR
Industry
Health Care

Nemaura Medical, Inc. operates as a holding company. The company is headquartered in New York City, New York and currently employs 25 full-time employees. The company went IPO on 2014-11-04. The firm is focused on developing sugarBEAT, which is a non-invasive, glucose monitoring system, for use by persons with Type I and Type II diabetes and used to screen pre-diabetic patients. SugarBEAT consists of disposable adhesive skin-patch containing a sensor, which is connected to a rechargeable wireless transmitter.The SugarBEAT works by extracting glucose from the skin into a chamber in the patch that is in direct contact with an electrode-based sensor .The sensor takes a measurement of the glucose reading every five minutes and sends the data by low energy blue tooth to a smart device such as mobile phone (both android and iOS).The data is recorded on the app and can be viewed in real time as well as storing all historic data for later evaluation as desired. The firm's subsidiaries include Region Green Limited.

N18A Intrinsic Value
Not Available

See Also

What is Nemaura Medical Inc's Depreciation & Amortization?
Depreciation & Amortization
479.7k USD

Based on the financial report for Dec 31, 2023, Nemaura Medical Inc's Depreciation & Amortization amounts to 479.7k USD.

What is Nemaura Medical Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
74%

Over the last year, the Depreciation & Amortization growth was 33%. The average annual Depreciation & Amortization growth rates for Nemaura Medical Inc have been 90% over the past three years , 74% over the past five years .

Back to Top